Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer

This publication has 25 references indexed in Scilit:

• An improved multiwell immunoassay using digoxigeninlabelled lectins to study the glycosylation of purified glycoproteins
  Biochemical Society Transactions, 1995
• Investigating the glycosylation of normal and ovarian cancer haptoglobins using digoxigenin-labelled lectins
  Glycoconjugate Journal, 1994
• Changes in the fucose content of haptoglobin in breast and ovarian cancer: Association with disease progression
  Glycoconjugate Journal, 1994
• Structural Analysis on the Sugar Chains of Human α1-Antitrypsin: Presence of Fucosylated Biantennary Glycan in Hepatocellular Carcinoma
  Archives of Biochemistry and Biophysics, 1993
• Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis
  British Journal of Cancer, 1991
• Serum alpha- 1 -proteinase inhibitor with abnormal properties in ovarian cancer
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1990
• Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer
  British Journal of Cancer, 1988
• Molecular basis of alpha-1-antitrypsin deficiency
  The American Journal of Medicine, 1988
• Uniformity of Glycans within Molecular Variants of α_l‐Protease Inhibitor with Distinct Affinity for Concanavalin A
  European Journal of Biochemistry, 1982
• Purification and chemical compositions of human α₁‐antitrypsin of the MM type
  FEBS Letters, 1973